These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33475868)

  • 1. German tariffs for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluations at the end of life.
    Dams J; Huynh E; Riedel-Heller S; Löbner M; Brettschneider C; König HH
    Eur J Health Econ; 2021 Apr; 22(3):365-380. PubMed ID: 33475868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Values for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluation at end of life.
    Huynh E; Coast J; Rose J; Kinghorn P; Flynn T
    Soc Sci Med; 2017 Sep; 189():114-128. PubMed ID: 28797940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Population Tariffs for the ICECAP-A Instrument for Hungary and their Comparison With the UK Tariffs.
    Farkas M; Huynh E; Gulácsi L; Zrubka Z; Dobos Á; Kovács L; Baji P; Péntek M
    Value Health; 2021 Dec; 24(12):1845-1852. PubMed ID: 34838283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ICEpop Capability Measure for Adults Instrument for Capabilities: Development of a Tariff for the Dutch General Population.
    Rohrbach PJ; Dingemans AE; Groothuis-Oudshoorn CGM; Van Til JA; Essers BA; Van Furth EF; Van den Akker-Van Marle ME
    Value Health; 2022 Jan; 25(1):125-132. PubMed ID: 35031091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the construct validity and responsiveness of the ICECAP-SCM capability wellbeing measure in a palliative care hospice setting.
    Myring G; Mitchell PM; Kernohan WG; McIlfatrick S; Cudmore S; Finucane AM; Graham-Wisener L; Hewison A; Jones L; Jordan J; McKibben L; Muldrew DHL; Zafar S; Coast J
    BMC Palliat Care; 2022 Jul; 21(1):121. PubMed ID: 35804325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuing end-of-life care: translation and content validation of the ICECAP-SCM measure.
    Gühne U; Dorow M; Grothe J; Stein J; Löbner M; Dams J; Coast J; Kinghorn P; König HH; Riedel-Heller SG
    BMC Palliat Care; 2021 Feb; 20(1):29. PubMed ID: 33557792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life of nursing home residents with dementia: validation of the German version of the ICECAP-O.
    Makai P; Beckebans F; van Exel J; Brouwer WB
    PLoS One; 2014; 9(3):e92016. PubMed ID: 24632775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A think-aloud study of the feasibility of patients with end-stage organ failure completing the ICECAP-SCM.
    Nwankwo H; Coast J; Hewison A; Kinghorn P; Madathil S; Bailey C
    Palliat Med; 2022 Dec; 36(10):1559-1569. PubMed ID: 36114631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods.
    Ratcliffe J; Couzner L; Flynn T; Sawyer M; Stevens K; Brazier J; Burgess L
    Appl Health Econ Health Policy; 2011; 9(1):15-27. PubMed ID: 21033766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scoring the Icecap-a capability instrument. Estimation of a UK general population tariff.
    Flynn TN; Huynh E; Peters TJ; Al-Janabi H; Clemens S; Moody A; Coast J
    Health Econ; 2015 Mar; 24(3):258-69. PubMed ID: 24254584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliciting SF-6Dv2 health state utilities using an anchored best-worst scaling technique.
    Osman AMY; Wu J; He X; Chen G
    Soc Sci Med; 2021 Jun; 279():114018. PubMed ID: 33993008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'The ICECAP-SCM tells you more about what I'm going through': A think-aloud study measuring quality of life among patients receiving supportive and palliative care.
    Bailey C; Kinghorn P; Orlando R; Armour K; Perry R; Jones L; Coast J
    Palliat Med; 2016 Jul; 30(7):642-52. PubMed ID: 26819326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eliciting preferences to the EQ-5D-5L health states: discrete choice experiment or multiprofile case of best-worst scaling?
    Xie F; Pullenayegum E; Gaebel K; Oppe M; Krabbe PF
    Eur J Health Econ; 2014 Apr; 15(3):281-8. PubMed ID: 23553075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing adolescent-specific health state values for economic evaluation: an application of profile case best-worst scaling to the Child Health Utility 9D.
    Ratcliffe J; Flynn T; Terlich F; Stevens K; Brazier J; Sawyer M
    Pharmacoeconomics; 2012 Aug; 30(8):713-27. PubMed ID: 22788261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Population Tariffs for the CarerQol Instrument for Hungary, Poland and Slovenia: A Discrete Choice Experiment Study to Measure the Burden of Informal Caregiving.
    Baji P; Farkas M; Golicki D; Prevolnik Rupel V; Hoefman R; Brouwer WBF; van Exel J; Zrubka Z; Gulácsi L; Péntek M
    Pharmacoeconomics; 2020 Jun; 38(6):633-643. PubMed ID: 32201921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australian Public Preferences for the Funding of New Health Technologies: A Comparison of Discrete Choice and Profile Case Best-Worst Scaling Methods.
    Whitty JA; Ratcliffe J; Chen G; Scuffham PA
    Med Decis Making; 2014 Jul; 34(5):638-54. PubMed ID: 24713695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter?
    Makai P; Looman W; Adang E; Melis R; Stolk E; Fabbricotti I
    Eur J Health Econ; 2015 May; 16(4):437-50. PubMed ID: 24760405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US.
    Hoefman RJ; van Exel J; Brouwer WBF
    Pharmacoeconomics; 2017 Apr; 35(4):469-478. PubMed ID: 28039617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring capability wellbeing in adults at different stages of life for use in economic evaluation of health and care interventions: a qualitative investigation in people requiring kidney care.
    Mitchell PM; Husbands S; Sanghera S; Caskey FJ; Scott J; Coast J
    Qual Life Res; 2021 Oct; 30(10):2863-2873. PubMed ID: 33973109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Empirical Comparison of Discrete Choice Experiment and Best-Worst Scaling to Estimate Stakeholders' Risk Tolerance for Hip Replacement Surgery.
    van Dijk JD; Groothuis-Oudshoorn CG; Marshall DA; IJzerman MJ
    Value Health; 2016 Jun; 19(4):316-22. PubMed ID: 27325322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.